EP0079771A1 — Electrodeposition of chromium and its alloys
Assigned to International Business Machines Corp · Expires 1983-05-25 · 43y expired
What this patent protects
A chromium electroplating electrolyte comprising a source of trivalent chromium ions, a complexant, a buffer agent and a sulphur species selected from sulphites and dithionites, the complexant being selected so that the stability constant K, of the chromium complex as defined her…
USPTO Abstract
A chromium electroplating electrolyte comprising a source of trivalent chromium ions, a complexant, a buffer agent and a sulphur species selected from sulphites and dithionites, the complexant being selected so that the stability constant K, of the chromium complex as defined herein is in the range 10 6 < K, < 10 ' 2 M -1 preferably the chromium ions have a molar concentration lower than 0.01 M. Complexants within this range include aspartic acid, iminodiacetic acid, nitrilotriacetic acid, 5-sulphosalicylic acid and citric acid.
Drugs covered by this patent
- Winlevi (CLASCOTERONE) · Sun Pharma
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.